tacrolimus ointment 0.1%
tacrolimus ointment 0.1% is a pharmaceutical drug with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
1
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Evaluation of the Efficacy of 0.08% Tacrolimus Nanoencapsulated Aqueous Solution Spray Vs. 0.1% Free Tacrolimus Commercial Ointment in the Treatment of Oral Lichen Planus
To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)
Study of 0416 Ointment in the Treatment of Atopic Dermatitis
Distribution of Tacrolimus in Skin, Atopic Dermatitis
Long-term Safety of Protopic in Atopic Eczema
Clinical Trials (6)
Evaluation of the Efficacy of 0.08% Tacrolimus Nanoencapsulated Aqueous Solution Spray Vs. 0.1% Free Tacrolimus Commercial Ointment in the Treatment of Oral Lichen Planus
To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)
Study of 0416 Ointment in the Treatment of Atopic Dermatitis
Distribution of Tacrolimus in Skin, Atopic Dermatitis
Long-term Safety of Protopic in Atopic Eczema
Short Term Growth in Children With Atopic Dermatitis
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6